Use of a self-rating scale to monitor depression severity in recurrent GP consultations in primary care - does it really make a difference? : A randomised controlled study
Autor: | Carl Wikberg, Malin André, E-L Petersson, Cecilia Björkelund, Maria E. H. Larsson, Jeanette Westman, Jörgen Thorn, Robert Eggertsen, Hans Ågren |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
Adult
Male medicine.medical_specialty medicine.drug_class Sick-leave General Practice Severity of Illness Index 03 medical and health sciences 0302 clinical medicine Quality of life (healthcare) Rating scale Intervention (counseling) Health care Medicine Humans 030212 general & internal medicine Medical prescription Psychiatry Referral and Consultation Depression (differential diagnoses) Psychiatric Status Rating Scales Depressive Disorder Primary Health Care business.industry Depression Disease Management Middle Aged Self-assessment instrument Primary care Antidepressive Agents Allmänmedicin Quality-of- life Adherence Sedative Sick leave Physical therapy Quality of Life Female Self Report Quality-of-life Sick Leave business Family Practice 030217 neurology & neurosurgery Research Article |
Zdroj: | BMC Family Practice |
Popis: | Background Little information is available about whether the use of self-assessment instruments in primary care affects depression course and outcome. The purpose was to evaluate whether using a depression self-rating scale in recurrent person-centred GP consultations affected depression severity, quality of life, medication use, and sick leave frequency. Methods Patients in the intervention group met their GP regularly at least 4 times during the 3 months intervention. In addition to treatment as usual (TAU), patients completed a self-assessment instrument (Montgomery-Asberg Depression Rating Scale) on each occasion, and then GPs used the completed instrument as the basis for a person-centred discussion of changes in depression symptoms. The control group received TAU. Frequency of visits in the TAU arm was the result of the GPs’ and patients’ joint assessments of care need in each case. Depression severity was measured with Beck Depression Inventory-II (BDI-II), quality of life with EQ-5D, and psychological well-being with the General Health Questionnaire-12 (GHQ-12). Data on sick leave, antidepressant and sedatives use, and care contacts were collected from electronic patient records. All variables were measured at baseline and 3, 6, and 12 months. Mean intra-individual changes were compared between the intervention and TAU group. Results There were no significant differences between the intervention and control group in depression severity reduction or remission rate, change in quality of life, psychological well-being, sedative prescriptions, or sick leave during the whole 12-month follow-up. However, significantly more patients in the intervention group continued antidepressants until the 6 month follow-up (86/125 vs 78/133, p |
Databáze: | OpenAIRE |
Externí odkaz: |